Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-28
DOI
10.3389/fmed.2020.00453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence for gastrointestinal infection of SARS-CoV-2
- (2020) Fei Xiao et al. GASTROENTEROLOGY
- The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients
- (2020) Yan‐Chao Li et al. JOURNAL OF MEDICAL VIROLOGY
- Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
- (2020) Abdul Mannan Baig et al. ACS Chemical Neuroscience
- Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
- (2020) Flávio A. Cadegiani AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- COVID-19, ACE2, and the cardiovascular consequences
- (2020) Andrew M. South et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
- (2020) M. Montopoli et al. ANNALS OF ONCOLOGY
- Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
- (2020) Wei Liu et al. CHINESE MEDICAL JOURNAL
- What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy
- (2020) Andy Goren et al. Dermatologic Therapy
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Androgen sensitivity gateway to COVID ‐19 disease severity
- (2020) Carlos Gustavo Wambier et al. DRUG DEVELOPMENT RESEARCH
- COVID-19-related myocarditis in a 21-year-old female patient
- (2020) In-Cheol Kim et al. EUROPEAN HEART JOURNAL
- Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models
- (2020) S. Natoli et al. EUROPEAN JOURNAL OF NEUROLOGY
- Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis
- (2020) Ka Shing Cheung et al. GASTROENTEROLOGY
- Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection
- (2020) Lu Lin et al. GUT
- First case of COVID-19 complicated with fulminant myocarditis: a case report and insights
- (2020) Jia-Hui Zeng et al. INFECTION
- Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
- (2020) Sandro La Vignera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cardiac and arrhythmic complications in patients with COVID‐19
- (2020) Adriano Nunes Kochi et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis
- (2020) Carlos J. Pirola et al. JOURNAL OF INFECTION
- Systematic Analysis of ACE2 and TMPRSS2 Expression in Salivary Glands Reveals Underlying Transmission Mechanism Caused by SARS‐CoV‐2
- (2020) Jukun Song et al. JOURNAL OF MEDICAL VIROLOGY
- Angiotensin‐converting enzyme‐2 ( ACE2 ), SARS‐CoV ‐2 and pathophysiology of coronavirus disease 2019 ( COVID ‐19)
- (2020) Arno R. Bourgonje et al. JOURNAL OF PATHOLOGY
- Gastrointestinal and Liver Manifestations in Patients with COVID-19
- (2020) I-Cheng Lee et al. Journal of the Chinese Medical Association
- Cutaneous manifestations in COVID‐19: a first perspective
- (2020) S. Recalcati JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- COVID-19 and Cutaneous manifestations
- (2020) Rujittika Mungmungpuntipantip et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Neurotropism of SARS-CoV 2: Mechanisms and manifestations
- (2020) Giancarlos Conde Cardona et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis
- (2020) Mauro Panigada et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
- (2020) Jean‐François Llitjos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Liver injury during highly pathogenic human coronavirus infections
- (2020) Ling Xu et al. LIVER INTERNATIONAL
- Neurologic Features in Severe SARS-CoV-2 Infection
- (2020) Julie Helms et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Obesity with Disease Severity among Patients with COVID‐19
- (2020) Markos Kalligeros et al. Obesity
- Obesity is associated with worse outcomes in COVID‐19: Analysis of Early Data From New York City
- (2020) Kaveh Hajifathalian et al. Obesity
- Does COVID-19 affect male fertility?
- (2020) Anis Abobaker et al. WORLD JOURNAL OF UROLOGY
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- (2020) Andy Goren et al. Journal of Cosmetic Dermatology
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Impact of sex and gender on COVID-19 outcomes in Europe
- (2020) Catherine Gebhard et al. Biology of Sex Differences
- Correction to: Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
- (2020) Han Zhu et al. Current Cardiology Reports
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?
- (2020) Sherief Musa Arab Journal of Gastroenterology
- Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
- (2020) Andrea Vecchiola et al. Frontiers in Endocrinology
- Renin-angiotensin system at the heart of COVID-19 pandemic
- (2020) Marco Alifano et al. BIOCHIMIE
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
- (2020) Dimitrios Giannis et al. JOURNAL OF CLINICAL VIROLOGY
- SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications
- (2020) Sonja Groß et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
- (2020) Leonidas Palaiodimos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
- (2020) Yanwei Li et al. PHARMACOLOGICAL RESEARCH
- SARS-CoV-2 and the testis: similarity with other viruses and routes of infection
- (2020) Walter D. Cardona Maya et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography
- (2020) D.C. Rotzinger et al. THROMBOSIS RESEARCH
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Spironolactone rescues renal dysfunction in obstructive jaundice rats by upregulating ACE2 expression
- (2018) Er-liang Kong et al. Journal of Cell Communication and Signaling
- Obesity and malnutrition similarly alter the renin–angiotensin system and inflammation in mice and human adipose
- (2017) Thales de Almeida Pinheiro et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells
- (2016) Benoît Lacombe et al. JOURNAL OF VIROLOGY
- Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in mice
- (2016) Wen-Jie Ji et al. Nanomedicine
- Spironolactone blocks Epstein–Barr virus production by inhibiting EBV SM protein function
- (2016) Dinesh Verma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-genomic effects of spironolactone and eplerenone in cardiomyocytes of neonatal Wistar rats: do they evoke cardioprotective pathways?
- (2015) Milla Marques Hermidorff et al. Biochemistry and Cell Biology
- Hypertension: Renin-Angiotensin-Aldosterone System Alterations
- (2015) L. te Riet et al. CIRCULATION RESEARCH
- Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade
- (2014) Naimeh Rafatian et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharideviainactivation of nuclear factor-κB
- (2014) Yoshiro Kato et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Pretreatment with mineralocorticoid receptor blocker reduces intestinal injury induced by ischemia and reperfusion: involvement of inhibition of inflammatory response, oxidative stress, nuclear factor κB, and inducible nitric oxide synthase
- (2014) Hale Sayan Ozacmak et al. JOURNAL OF SURGICAL RESEARCH
- The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis
- (2014) Lei Zhang et al. LABORATORY INVESTIGATION
- Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models
- (2013) Gissela B Lieber et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of mineralocorticoid receptor and renin–angiotensin–aldosterone system in adipocyte dysfunction and obesity
- (2013) Alessandra Feraco et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Spironolactone Attenuates Bleomycin-Induced Pulmonary Injury Partially via Modulating Mononuclear Phagocyte Phenotype Switching in Circulating and Alveolar Compartments
- (2013) Wen-Jie Ji et al. PLoS One
- Role of renin–angiotensin–aldosterone system in adipose tissue dysfunction
- (2012) Fei Jing et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis
- (2010) Yumiko Imai et al. CIRCULATION JOURNAL
- Mineralocorticoid receptor activation in obesity hypertension
- (2009) Miki Nagase et al. HYPERTENSION RESEARCH
- Effect of mineralocorticoid receptor blockade on the renal renin–angiotensin system in Dahl salt-sensitive hypertensive rats
- (2009) Aoshuang Zhu et al. JOURNAL OF HYPERTENSION
- Spironolactone exhibits direct renoprotective effects and inhibits renal renin–angiotensin–aldosterone system in diabetic rats
- (2008) Masateru Taira et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response
- (2008) Daniela Fraccarollo et al. HYPERTENSION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now